Related Experiment Video
Updated: Aug 15, 2025

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Clinical characteristics of 14 pediatric mycoplasma pneumoniae pneumonia associated thrombosis: a retrospective study
1Department of Respiratory Medicine, Tianjin Children's Hospital (Children's Hospital of Tianjin University), Tianjin, China.
Objective:
This study aimed to investigate the clinical characteristics and long-term prognosis of mycoplasma pneumoniae pneumonia (MPP)-associated thrombosis and to gain a better understanding of the diagnosis and treatment of the disease.
Methods:
The medical records of 14 children with MPP-associated thrombosis between January 2016 and April 2020 were retrospectively reviewed at the Tianjin Children's Hospital.
Results:
The ages of the patients ranged from 3 to 12 years old. Among the 14 cases, there were five cases of pulmonary embolism, two cases of cerebral infarction, one case of splenic infarction, one case of cardiac embolism, two cases of cardiac embolism with comorbid pulmonary embolism, one case of internal carotid artery and pulmonary embolism, one case of combined internal carotid artery and the cerebral infarction, and one case combined cardiac embolism and lower limb artery embolism. All cases had elevated D-dimer levels. After thrombolysis and anticoagulation therapy, three cases with cerebral embolism still suffered from neurological sequelae. In contrast, the remaining cases did not develop complications.
Conclusion:
MPP-associated thrombosis can occur in any vessel of the body. Thrombosis-associated symptoms may be complex and non-specific. Elevated D-dimer levels in a child with refractory mycoplasma pneumoniae pneumonia should raise suspicion of thrombosis. The long-term prognosis of thrombosis was favorable after the timely administration of anticoagulant therapy.
Insights
Mycoplasma pneumoniae pneumonia (MPP)-associated thrombosis can affect any blood vessel, presenting with varied symptoms. Early diagnosis and prompt anticoagulant therapy lead to a favorable prognosis for most pediatric patients.
Area of Science:
- Pediatric Thrombosis
- Infectious Disease Complications
- Respiratory Medicine
Background:
- Mycoplasma pneumoniae pneumonia (MPP) is a common childhood infection.
- MPP can lead to serious extrapulmonary complications, including thrombosis.
- Understanding MPP-associated thrombosis is crucial for timely diagnosis and management.
Purpose of the Study:
- To investigate the clinical characteristics of pediatric patients with MPP-associated thrombosis.
- To evaluate the long-term prognosis of MPP-associated thrombosis.
- To improve the diagnostic and therapeutic strategies for this condition.
Main Methods:
- Retrospective review of medical records of 14 children diagnosed with MPP-associated thrombosis.
- Data collected from January 2016 to April 2020 at Tianjin Children's Hospital.
- Analysis of clinical presentation, thrombotic events, D-dimer levels, and treatment outcomes.
Main Results:
- Ages ranged from 3 to 12 years; various thrombotic events observed, including pulmonary embolism, cerebral infarction, and cardiac embolism.
- All patients presented with elevated D-dimer levels.
- Three cases with cerebral embolism experienced neurological sequelae; others had favorable outcomes after thrombolysis and anticoagulation.
Conclusions:
- MPP-associated thrombosis can manifest in diverse vascular beds with non-specific symptoms.
- Elevated D-dimer in refractory MPP warrants suspicion for thrombosis.
- Timely anticoagulant therapy is associated with a good long-term prognosis in pediatric MPP-associated thrombosis.
More Related Videos
08:25Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pneumonia II: Pathophysiology
Acute Pyelonephritis II: Diagnostic Studies and Management
Myocarditis II: Clinical Features and Diagnostic Tests